Forte Biosciences (FBRX) Misses Q3 EPS by 433c

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• Philip Morris (PM) Raises Quarterly Dividend 8.8% to $1.60; 3.4% Yield